BSc., MSc., PhD.
Pharmaceutical Development Officer
Dr Brendon Woodhead has a solid academic foundation with a PhD in Pharmaceutical Science (Kings College London, UK) along with a successful 30+ year career in the pharmaceutical/medtech and consumer healthcare industries. Dr Woodhead combines strong medical scientific expertise, with strategic insight and commercial acumen. He is skilled at researching and collating complex data, distilling the medical/business relevance and formulating strategies.
Dr Woodhead has had roles in both big Pharma and small start-ups and has lead a number of strategic focus teams whose primary role was to provide leadership, promoting a culture of continuous improvement and operational excellence in such areas such as Quality by Design (QbD), Risk management, Design for Manufacture (DFM), Technical advancements and providing feedback and advice to external agencies such as the USFDA, British Pharmacopeia and the MHRA.
Dr Woodhead has significant experience in both R&D and commercial manufacture developing new medicines and medical devices for treatments of diseases in areas such as respiratory, AIDs, pain relief, neurology, skin disorders and oncology. Dr Woodhead has also experience in regulatory affairs with successful submissions to global Regulatory agencies such as the USFDA, MHRA, TGA and Medsafe.
In his various roles, Dr Woodhead has managed both staff and departmental budgets and has provided business strategies and forecasting at the board level. He has also been successful in applying and receiving both Australian and New Zealand government grants.